Prescient Surgical, based in San Carlos, California, just won FDA marketing clearance for its CleanCision Wound Retraction and Protection System. The device, which combines a retractor with infection control mechanisms, aims to prevent surgical site infections, a common, dangerous, and costly problem.
The CleanCision System protects surgical wounds by covering them and the surrounding tissues with a waterproof material, while providing irrigation and suction along the edge of the wound.
The device is placed into the wound and pulled apart in an intuitive fashion, opening up like a flower. The clinical staff can choose the irrigation liquid to pump through the CleanCision System, which helps to wash away any bacteria that may be present on the wound.
So far, in studies of the device, the CleanCision system was able to achieve a 61% reduction in surgical site infections, an impressive achievement.
“We are initially focusing on abdominal surgery and particularly colorectal surgery, where the risk, frequency and severity of surgical site infection is high and the need is acute,” said Jonathan Coe, cofounder, president and CEO of Prescient Surgical. “Our team collaborated closely with leading hospitals in abdominal surgery to create a technology platform and product that could be used in the full range of open and minimally invasive approaches utilized in their procedures. The result is an intuitive system that readily integrates into surgical workflow,” he added.
Product page: CleanCision…
Via: Prescient Surgical…